“…Many patients with ARDS survive in the acute phase, but then die from significant lung fibrosis. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…BACKGROUND: Extracorporeal membrane oxygenation (ECMO) has become increasingly accepted as a life-saving procedure for patients with severe acute respiratory distress syndrome (ARDS). This study investigated the relationship between cumulative fluid balance (CFB) and outcomes in adult ARDS patients treated with ECMO. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…BACKGROUND: Coronavirus disease 2019 (COVID-19) is a serious illness caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and in severe cases associated with acute respiratory distress syndrome (ARDS). OBJECTIVE: To describe the clinical characteristics of patients with ARDS-COVID-19. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…The high mortality rate of patients with severe acute respiratory distress syndrome (ARDS) warrants aggressive clinical intervention. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Since its first description, the acute respiratory distress syndrome (ARDS) has been acknowledged to be a major clinical problem in respiratory medicine. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…BACKGROUND: Neutral endopeptidase (NEP), an enzyme that cleaves inflammatory bioactive peptides, may play a protective role in the pathogenesis of acute lung injury (ALI) and acute respiratory distress syndrome (ARDS). However, its low extracellular activity hinders the precise measurement of changes that take place during ALI/ARDS. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…INTRODUCTION: Acute respiratory distress syndrome (ARDS) is a common disease in critically ill patients that has a high incidence and mortality rate worldwide. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…BACKGROUND: Influenza virus (IV)-related pathophysiology suggests that the prognosis of acute respiratory distress syndrome (ARDS) due to IV could be different from the prognosis of ARDS due to other causes. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Introduction Cytokine release syndrome in COVID-19 is characterized by hyperinflammation, which manifests as acute respiratory distress syndrome (ARDS), multiorgan failure, and high inflammatory parameters. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…BACKGROUND: The recombinant protein diannexin can inhibit platelet-mediated events, which contribute to acute respiratory distress syndrome (ARDS). Here, we investigated the effect of diannexin and its effect on heme oxygenase-1 (HO-1) in ARDS. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Patients with mild to moderate ARDS and pneumomediastinum/pneumothorax (n = 25) received High Flow Nasal Cannula (HFNC), while patients with severe ARDS and pneumomediastinum/pneumothorax underwent HFNC (n = 10) or invasive mechanical ventilation (IMV) (n = 10). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Introduction Acute respiratory distress syndrome (ARDS) after mild traumatic brain injury (TBI) can be associated with significant morbidity and mortality. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Acute respiratory distress syndrome (ARDS) is an inflammatory process in the lungs that induces non-hydrostatic protein-rich pulmonary edema. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…In obese patients with influenza disease, a significant increased level of IL-8 was found. When comparing viral ARDS with bacterial ARDS, the level of IL-8, IL-17 and TNFα was significantly higher in bacterial ARDS and IL-12 was increased only in viral ARDS. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…• Illustrate imaging findings of multi-parametric CMR approach in the diagnosis of cardiovascular involvement in various ARDs; • Review the CMR signatures for risk stratification, prognostication, and guiding treatment strategies in ARDs; • Describe the utility of routine and advanced CMR sequences in identifying cardiotoxicity related to immunomodulators and disease-modifying agents in ARDs; • Discuss the limitations of CMR, recent advances, current research gaps, and potential future developments in the field.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…A patient complicated with ARDS and HLH is unusual in critical care, and few case reports are present in PudMed. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Such a paradigm shift is urgently needed in acute respiratory distress syndrome (ARDS), an acute lung condition with no successful therapies and a 40% mortality rate. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Despite the increased understanding of the molecular pathogenesis of ARDS, specific targeted treatments for ARDS have yet to be developed. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…With increasing in-depth studies of ALI/ARDS, significant breakthroughs have been made, however, there are still no effective pharmacological therapies for treatment of ALI/ARDS. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Acute respiratory distress syndrome (ARDS) is associated with high morbidity and mortality, and current management has a dramatic impact on healthcare resource utilization. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso